VALENCIA, Calif., Nov. 20, 2015 (GLOBE NEWSWIRE) -- Envoy Group Corp (OTCBB:ENVV) is pleased to announce it has entered into discussions to acquire Tryst Electronic Smoking Products (Tryst) the market leader in the Electronic Cigar industry and a maker of a full line of premier Electronic Smoking Devices.
Tryst offers an incredible array of disposable electronic smoking products consisting of E-Cigars, E-Cigarettes, E-Hookahs and E-Shisha. Tryst has focused extensively on quality and provides a large and unique variety of proprietary flavors and is the current market leader in the E-Cigar industry with their Rubusto and Panatella E-Cigars.
Envoy sees huge opportunity in the burgeoning electronic smoking product market. Within the last five years the demand has experienced over 20 times growth and to-date the electronic smoking device market has burgeoned to 1.7 billion in 2015. Industry analysts are expecting a further fivefold growth just within the next two years to nearly 10 billion. Envoy recognizes the incredible appeal of Tryst's diverse products to consumers and identifies they will become a leader in all spectrums of this marketspace.
Harp Sangha, Envoy's CEO and Chairman states, "We are incredibly pleased to be working with the Tryst management team. The Tryst products are state of the art and top of the line. The Tryst line of products are making rapid inroads to this expanding market and with Envoy we hope to quickly help the products develop domestically and globally."
For further information please see our investor profile available on our website: www.envoygroupcorp.com
Safe Harbor Statements
Certain information contained in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates", "intends" or "believes", or that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur", or "be achieved". Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.